Upgrade to SI Premium - Free Trial

Citi Reiterates Buy Rating on Novartis (NVS)

October 15, 2019 3:41 AM
Citi analyst Andrew Baum reiterated a Buy rating and CHF99.00 price target on Novartis (NOVN:SW) (NYSE: NVS).The analyst comments "Despite ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Intl Ratings

Next Articles